Sanofi India Cash Flow
- Market cap
- ₹6,771 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹2,116.73 – ₹3,968.87
In the year ended FY25, Sanofi India generated ₹406 crore from operating activities, invested ₹271 crore and paid out ₹102 crore on financing activities. Net cash flow for the year was ₹33.85 crore. Free cash flow was ₹169 crore.
Sanofi India cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 406 |
| Cash from investing activities | -271 |
| Cash from financing activities | -102 |
| Net cash flow | 33.85 |
| Capital expenditure | 237 |
| Free cash flow | 169 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Sanofi India cash flow — frequently asked questions
What is Sanofi India's operating cash flow?
Sanofi India's cash flow from operating activities was ₹406 crore in the year ended FY25.
What is Sanofi India's free cash flow?
Sanofi India's free cash flow — operating cash flow minus capital expenditure — was ₹169 crore in FY25, after capital expenditure of ₹237 crore.
How much did Sanofi India spend on investing activities?
Net cash used in investing activities was ₹271 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade Sanofi India With ATS
Track SANOFI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.